Executive Chairman of the Board
Maravai LifeSciences
Carl co-founded Maravai in 2014 and served as its Chief Executive Officer for eight years, during which time he oversaw an extraordinary period of growth and operational expansion along with the company’s initial public offering. He has over 35 years of sales, marketing and general management leadership in the diagnostics and life sciences industries. Prior to founding Maravai LifeSciences, Mr. Hull was CEO of Gen-Probe. He focused the company’s strategy to take full advantage of its core molecular diagnostics and automation strengths. During his tenure, the value of Gen-Probe doubled, culminating in a successful sale of the business in 2012 to Hologic. Earlier in his career, Mr. Hull held numerous sales, marketing and management positions for Abbott Laboratories, Ventana Medical Systems (acquired by Roche), Applied Imaging (now part of Danaher) and Applied Biosystems (now part of Thermo Fisher Scientific). Mr. Hull holds an MBA from the University of Chicago and a B.A. in political science and international relations from the Johns Hopkins University.